MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive (loss) income
-$50,661K
(-144.86%↓ Y/Y)
Net (loss) income
-$50,003K
(-144.30%↓ Y/Y)
Total other
comprehensive (loss) gain
-$658K
(-1500.00%↓ Y/Y)
Interest income
(expense), net
$3,397K
(17.58%↑ Y/Y)
Other income
$18K
(-35.71%↓ Y/Y)
(loss) income before
income taxes
-$50,003K
(-143.80%↓ Y/Y)
Unrealized (loss) gain on
marketable securities
-$658K
(-1500.00%↓ Y/Y)
Total other income
(expense)
$3,415K
(17.07%↑ Y/Y)
(loss) income from
operations
-$53,418K
(-148.02%↓ Y/Y)
Revenue
$6,229K
(-96.07%↓ Y/Y)
Total operating
expenses
$59,647K
(26.03%↑ Y/Y)
Research and development
$39,673K
(21.41%↑ Y/Y)
Sales, general and
administrative
$19,974K
Back
Back
Income Statement
source: myfinsight.com
Stoke Therapeutics, Inc. (STOK)
Stoke Therapeutics, Inc. (STOK)